Open AccessPrognostic value of programmed death-ligand 1 (PD-L1) expression in ovarian clear cell carcinoma
Author(s) -
Jun Zhu,
Hao Wen,
Rui Bi,
Yong Wu,
Xiaohua Wu
Publication year - 2017
Publication title -
journal of gynecologic oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.358
H-Index - 37
eISSN - 2005-0399
pISSN - 2005-0380
DOI - 10.3802/jgo.2017.28.e77
Subject(s) - medicine , hazard ratio , pd l1 , tissue microarray , immunohistochemistry , oncology , proportional hazards model , stage (stratigraphy) , clear cell carcinoma , ovarian carcinoma , ovarian cancer , carcinoma , cancer , immunotherapy , confidence interval , paleontology , biology
PD-L1(high) might serve as a risk factor for PFS and OS in patients with OCCC. It is possible that immunotherapy targeting PD-L1 pathway could be used in OCCC.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom